Financeiro
BRBI11 — BRBI BR PARTNERS S.A
CNPJ 10.739.356/0001-03 · listed classes: BRBI11 · CVM code 25860
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE ⟶ | 30.2%! | 26.1%! | 18.7%! | 0.0%! | 23.8%! | 22.1%! |
| ROIC | — | — | — | — | — | — |
| ROA ⟶ | 11.7%! | 7.3%! | 2.7%! | 1.7%! | 1.5%! | 1.1%! |
| Gross margin ⟶ | 3.8% | 94.5%! | 100.0%! | 100.0%! | 100.0%! | 100.0%! |
| EBIT margin ⟶ | 10.9% | 45.1%! | 27.8%! | 4.5%! | 6.3%! | 6.6%! |
| Net margin ⟶ | 7.3% | 61.2%! | 58.6%! | 62.9%! | 53.1%! | 54.7%! |
| Revenue growth (1y) ⟶ | — | 19.7%! | 10.8%! | -1.7%! | 47.9%! | -12.3%! |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 11.1%! |
| Net debt/EBITDA ⟶ | — | -6.79x! | -14.20x! | — | — | -3.76x! |
| Current ratio ⟶ | 2.17x | 1.35x! | 1.12x! | 1.07x! | 1.05x! | 1.04x! |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 79.8 | 49.5 | 62.0% | 283.0 | 5.60 | 2024-05-09 |
| 2024T2 | 92.7 | 52.0 | 56.1% | 154.8 | 5.42 | 2024-08-08 |
| 2024T3 | 104.5 | 50.1 | 48.0% | 119.8 | 5.60 | 2024-11-07 |
| 2025T1 | 81.9 | 43.1 | 52.7% | 26.0 | 6.11 | 2025-05-08 |
| 2025T2 | 77.7 | 45.2 | 58.1% | 37.4 | 6.28 | 2025-08-07 |
| 2025T3 | 71.2 | 42.2 | 59.3% | 47.5 | 7.48 | 2025-11-06 |
| 2026T1 | 88.2 | 37.7 | 42.8% | 33.7 | 7.21 | 2026-05-07 |
| 2026T2 | 85.9 | 35.1 | 40.8% | 26.2 | 5.49 | 2026-08-06 |
Full series, every quarter: GET /empresas/BRBI11/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2026 | R$ 0.3600 | 2 |
| 2025 | R$ 1.8600 | 4 |
| 2024 | R$ 1.9500 | 5 |
| 2023 | R$ 1.3200 | 4 |
| 2022 | R$ 1.3800 | 3 |
Piotroski F-Score 2/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2020 | DRE 3.02 | -1,177.0 | -17.4 |
| 2020 | DRE 3.01 | 1,223.7 | 189.3 |
| 2020 | BPP 2.01.04 | 0.0 | 305.0 |
| 2022 | DRE 3.11.01 | 147.1 | 0.0 |
| 2020 | DRE 3.03 | 46.7 | 171.8 |
| 2022 | BPP 2.01 | 6,943.6 | 7,066.8 |
| 2022 | BPP 2.01.04 | 6,889.1 | 6,775.3 |
| 2020 | BPP 2.01 | 340.2 | 408.9 |
This company appears in
Other companies in Financials
33 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/BRBI11/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 1,302 sessions, 2021-06-21 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:39 UTC. If this does not match /saude, you are reading a cached copy.